Author:
James Anna,Hedlin Gunilla
Publisher
Springer Science and Business Media LLC
Subject
Medicine (miscellaneous),Immunology and Allergy
Reference97 articles.
1. Newacheck PW, Halfon N. Prevalence, impact, and trends in childhood disability due to asthma. Arch Pediatr Adolesc Med. 2000;154(3):287–93.
2. Mallola J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A, the ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol (Madr). 2013;41(2):73–85.
3. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135:299–310 This review provides new knowledge of biomarkers as a help in finding the right biologic medication to the right patient, and the authors also speculate on the possibility of a more personalized approach to medication of individual patients as opposed to the “one drug fits all” approach that we have today with inhaled corticosteroid and bronchodilators. They also describe limitations to this approach and need for further studies.
4. Global Initiative for asthma. Global strategy for asthma management and prevention. Updated 2015. http://www.ginasthma.org/lovcal/uploads/files/GINA_Report_2015.pdf.20th May 2015 . This is the latest update on the GINA guidelines—there are many useful overviews of suggested approaches to diagnosis, monitoring, and treatment of asthma in this extensive document.
5. Buchvald F, Bisgaard H. FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. Am J Respir Crit Care Med. 2001;163(3 Pt 1):699–704.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献